FDA pushes new heart warning on AZ's Seroquel

AstraZeneca is adding a new heart warning to the labels of Seroquel, its blockbuster antipsychotic drug, at the FDA's request, the New York Times reports. The warning concerns combining Seroquel with other drugs linked to an arrhythmia that can cause sudden cardiac arrest. Report